NeuroVive Pharmaceutical AB Company Profile

12:27 EDT 21st June 2018 | BioPortfolio

NeuroVive Pharmaceutical AB ( is a Swedish drug development company whose primary mission is to develop drugs for the treatment of acute brain injury, reperfusion injury in myocardial infarction and other acute injuries where mitochondrial energy production is critical for clinical outcome. The research and development program focuses on developing new variants of cyclophilin inhibitors for neuro- and cardioprotection and studying ways of transporting these drugs across the blood-brain barrier to the central nervous system.

NeuroVive´s shares are listed on the Swedish trading platform AktieTorget ( The AktieTorget market is focused on emerging, entrepreneurial businesses through an electronic trading system supplied by the OMX Nordic stock exchange in Stockholm, Sweden.


Medicon Village
Scheelevägen 2
SE-223 81


Phone: +46 [0] 46 275 62 20
Fax: +46 [0] 46-888 83 48

News Articles [285 Associated News Articles listed on BioPortfolio]

NeuroVive out─licenses targeted LHON therapy to BridgeBio Pharma

NeuroVive Pharmaceutical AB and BridgeBio Pharma jointly announced that BridgeBio has entered into an exclusive licensing agreement for a subset of succinate prodrug chemistry under NeuroVive's NVP015

Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)

LUND, Sweden, 27 April, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) ("NeuroVive") today on 27 April 2018 held its Annual General Meeting (AGM). A summar...

NeuroVive Initiates Collaboration With Leading US TBI Research Organization

"We are delighted to add NeuroVive as an industrial partner to TRACK-TBI. The promising results with NeuroVive's TBI candidate drug NeuroSTAT has garnered our attention. Read more...

BRIEF—NeuroVive partners with brain injury experts to advance candidate

Stockholm-based NeuroVive Pharmaceutical is to partner with TRACK-TBI, a network of US-based traumatic…

NeuroVive Pharmaceutical (NVP) - KL1333 Ph I positive; rights issue oversubscribed

Edison Investment Research - Pharmaceutical & healthcare - NeuroVive Pharmaceutical: On 27 April 2018, NeuroVive announced that the planned rights issue was oversubscribed (104%), delivering SEK78.5m ...

Nasdaq Stockholm AB: Listing of equity rights in NeuroVive Pharmaceutical AB (106/18)

As from June 8, 2018, the equity rights in NeuroVive Pharmaceutical AB, NVP TO 5, will be admitted to trading on the list for Equity rights. Trading will continue up to and including November 28, 2...

NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project

LUND, Sweden" Jan. 29, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced a breakthrough in the company's project NVP025 for developing treatment...

NeuroVive Pharmaceutical (NVP) - Rights issue to reach several R&D events

Edison Investment Research - Pharmaceutical & healthcare - NeuroVive Pharmaceutical: NeuroVive’s planned rights issue (subject to approval at the EGM) is expected to bring in a minimum guarantee...

PubMed Articles [459 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1033 Associated Companies listed on BioPortfolio]

NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB ( is a Swedish drug development company whose primary mission is to develop drugs for the treatment of acute brain injury, reperfusion injury in myocard...

Selcia and NeuroVive

Selcia Limited ( is a leading worldwide provider of contract research services in integrated drug discovery, fragment screening, medicinal chemistry and GMP ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

Cypress Pharmaceutical, Inc.

Cypress Pharmaceutical, Inc., founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading...


Our Pharmaceutical products solution is focused to help manage the success of client’s business. We thrive on our innovative methodology to provide solution at an unmatched time to delivery and pr...

More Information about "NeuroVive Pharmaceutical AB" on BioPortfolio

We have published hundreds of NeuroVive Pharmaceutical AB news stories on BioPortfolio along with dozens of NeuroVive Pharmaceutical AB Clinical Trials and PubMed Articles about NeuroVive Pharmaceutical AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroVive Pharmaceutical AB Companies in our database. You can also find out about relevant NeuroVive Pharmaceutical AB Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record